Brief: Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment
Yesterday 23:19
BRIEF-Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment Oct 22 (Reuters) - Charles River Laboratories International, Inc. CRL.N:
CHARLES RIVER, LABCORP, AND FDA COLLABORATE TO VALIDATE NEW PRECLINICAL METHODS FOR ABUSE POTENTIAL ASSESSMENT
CHARLES RIVER LABORATORIES INTERNATIONAL - AGREEMENT ESTABLISHES JOINT FRAMEWORK FOR STANDARDIZED ABUSE POTENTIAL METRICS IN PRECLINICAL MODELS
Source text: ID:nBw7wyCW6a
Further company coverage: CRL.N
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Labcorp Holdings
See all newsBrief: Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment
Brief: Labcorp Declares Quarterly Dividend
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
Live Markets: Split US congress after 2026 midterms could boost healthcare stocks, Mizuho says